Image
|
Figure Caption
Figure 2
Faberidilactone A inhibits the proliferation of HepG2 cells. HepG2 cells were treated with faberidilactone A (2.5, 5, and 10 µM) for 48 h. Morphological changes in faberidilactone A-treated HepG2 cells were observed with a microscope, bar: 100 µm.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Molecules